AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Carlat Psychiatry Podcast
MDMA: What Went Wrong Part 1
Jun 10, 2024
Chris Aiken, MD, a psychiatrist specializing in psychedelic therapy, discusses the FDA panel's rejection of MDMA-assisted psychotherapy and the challenges in accessing such therapy in the United States. The podcast explores contrasting experiences in MDMA therapy, origins of MDMA in therapy, the role of therapists in maintaining boundaries, and the positive effects of MDMA on PTSD symptoms.
20:01
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ethical concerns surfaced in MDMA therapy due to boundary violations and sexual misconduct during clinical trials.
- Despite MDMA's potential in treating PTSD, its reclassification as ecstasy underscores ethical and safety dilemmas.
Deep dives
MDMA-Assisted Therapy for PTSD: A Cautionary Tale
The rejection of MDMA-assisted psychotherapy for PTSD by an FDA panel has stirred discussions. A decade-old video featuring a woman's breakthrough under MDMA effects contrasts with a disturbing 2014 incident during a MAPS clinical trial session. This incident involved alleged boundary violations and sexual misconduct by therapists, shedding light on ethical concerns within psychedelic therapy practices.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode